Jun.2023 – May 2026
The project aims to study and develop a predictive analysis model based on advanced AI tools, for the early recognition of heart failure in diabetic/dialysis patients, combining Personalized Medicine approaches and methods, and through innovative epigenetic and clinical biomarkers. The ultimate goal is the development of a digital application to support the management and clinical governance of patients, interoperable with healthcare systems, in compliance with directives on medical devices, privacy and data security.
Mare Group annually invests in Research and Development to promote and expand projects, technologies and the ideas of its team.
Every year, the Group faces bigger challenges in wanting to become a reference point for companies in Southern Italy. Find out more about other projects.